Nivolumab + Ipilimumab as immunotherapeutic boost in metastatic urothelial carcinoma: a nonrandomized clinical trial
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[May 9, 2024]
|
| In: |
JAMA oncology
Year: 2024, Volume: 10, Issue: 6, Pages: 755-764 |
| ISSN: | 2374-2445 |
| DOI: | 10.1001/jamaoncol.2024.0938 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/jamaoncol.2024.0938 |
| Author Notes: | Marc-Oliver Grimm, Martin Schostak, Christine Barbara Grün, Wolfgang Loidl, Martin Pichler, Uwe Zimmermann, Bernd Schmitz-Dräger, Thomas Steiner, Florian Roghmann, Günter Niegisch, Christian Bolenz, Marc Schmitz, Gustavo Baretton, Katharina Leucht, Ulrike Schumacher, Susan Foller, Friedemann Zengerling, Johannes Meran |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 2374-2445 |
| DOI: | 10.1001/jamaoncol.2024.0938 |